perlane

Perlane is a brand of injectable dermal filler used in cosmetic medicine. It consists of stabilized hyaluronic acid (NASHA) gel with cross-linked polymers, designed for deep dermal or subcutaneous injections. Perlane is a thicker formulation than some other hyaluronic acid fillers, enabling greater lifting and volume replacement when placed into deeper facial layers.

The product is indicated for restoring facial volume and smoothing deep wrinkles and folds, particularly in the midface region. Common applications include correction of nasolabial folds and augmentation of cheek contours. Treatments are typically performed by trained physicians or clinicians using local anesthesia; injections are delivered with a fine needle or cannula into the deep dermis or subcutaneous tissue, with careful attention to facial anatomy to minimize risks.

Duration of effect is usually around 6 to 12 months, though longevity varies with the treated area, amount injected, individual metabolism, and technique. Safety considerations include the usual temporary injection-site reactions such as redness, swelling, bruising, and tenderness. Rare but serious risks include infection, allergic reaction, and vascular compromise; hyaluronidase can dissolve the filler if needed. As with other hyaluronic acid fillers, results can be reversed if necessary, and patients should follow post-treatment guidance to reduce adverse effects.

History and availability: Perlane was developed by Q-Med AB and later became part of broader restorative lines after corporate acquisitions, with branding and product naming varying by country. In some markets it has been marketed within the Restylane family or as a separate product under different names. Perlane is intended for adult use and should be administered by qualified healthcare professionals.